CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Athersys, Inc  (ATHX)
Other Ticker:  
 
 

ATHX's Revenue Growth by Quarter and Year

Athersys, Inc's Revenue results by quarter and year




ATHX Revenue (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December - 1.53 0.31 0.40
III Quarter September 2.32 0.40 0.60 0.22
II Quarter June 19.39 1.47 15.46 0.73
I Quarter March 1.07 0.98 10.61 0.24
FY   22.78 4.38 26.98 1.59



ATHX Revenue third quarter 2018 Y/Y Growth Comment
Athersys, Inc achieved in the third quarter, above Company average Revenue surge of 480.25% year on year, to $ 2.32 millions.

Looking into third quarter results within Major Pharmaceutical Preparations industry 18 other companies have achieved higher Revenue growth. While Athersys, Inc' s Revenue doubling of 480.25% ranks overall at the positon no. 249 in the third quarter.




ATHX Revenue ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - 393.55 % -22.5 % 37.93 %
III Quarter September 480.25 % -33.33 % 172.73 % -43.59 %
II Quarter June 1219.05 % -90.49 % 2017.81 % 2.82 %
I Quarter March 9.18 % -90.76 % 4320.83 % -
FY   - -83.77 % 1596.86 % -

Financial Statements
Athersys, Inc's third quarter 2018 Revenue $ 0.00 millions ATHX's Income Statement
Athersys, Inc's third quarter 2017 Revenue $ 0.00 millions Quarterly ATHX's Income Statement
New: More ATHX's historic Revenue Growth >>


ATHX Revenue (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - 282.5 % -48.33 % 81.82 %
III Quarter September -88.03 % -72.79 % -96.12 % -69.86 %
II Quarter June 1712.15 % 50 % 45.71 % 204.17 %
I Quarter March -30.07 % 216.13 % 2552.5 % -17.24 %
FY (Year on Year)   - -83.77 % 1596.86 % -




Revenue third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #19
Healthcare Sector #59
Overall #249

Revenue Y/Y Growth Statistics
High Average Low
657.16 % 79.14 % -80.64 %
(Dec. 30, 2015)   (Mar 31 2017)
Revenue third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #19
Healthcare Sector #59
Overall #249
Revenue Y/Y Growth Statistics
High Average Low
657.16 % 79.14 % -80.64 %
(Dec. 30, 2015)   (Mar 31 2017)

Revenue by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Athersys, Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
2578.03 % 263.48 % -96.26 %
(Dec 31 2015)  


ATHX's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2018 Athersys, Inc reported fall in Revenue from the previous quarter by -88.03% to $ 2.32 millions, from $ 19.39 millions declared a quarter before.

When you evaluate recent slump in the III. Quarter 2018, you should take into consideration, that commonly III. Quarter Revenue emerge sluggish in contrast to the quarter before

Within Major Pharmaceutical Preparations industry 63 other companies have achieved higher Revenue quarter on quarter growth. While Athersys, Inc's Revenue growth quarter on quarter, overall rank is 1824.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #64
Healthcare Sector #220
Overall #1824
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #64
Healthcare Sector #220
Overall #1824
Revenue Q/Q Growth Statistics
High Average Low
2578.03 % 263.48 % -96.26 %
(Dec 31 2015)  


ATHX's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2018 Athersys, Inc realized fall in Revenue from the previous quarter by -88.03% to $ 2.32 millions, from $ 19.39 millions achived in the previous reporting period.

This is not huge problem, as Athersys, Inc's Revenue frequently gravitate to dip in this quarter Ŕlex Ortiz, an industry expert told.

Within Major Pharmaceutical Preparations industry 63 other companies have achieved higher Revenue quarter on quarter growth. While Athersys, Inc's Revenue growth quarter on quarter, overall rank is 1824.


Athersys, Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Sep 30 2017)
Cumulative Revenue 12 Months Ending $ 24.31 $ 22.38 $ 4.46 $ 4.38 $ 3.16
Y / Y Revenue Growth (TTM) 668.45 % 566.39 % -74.27 % -83.76 % -88.31 %
Year on Year Revenue Growth Overall Ranking # 16 # 39 # 2771 # 3660 # 3566
Seqeuential Revenue Change (TTM) 8.59 % 401.55 % 1.89 % 38.48 % -5.84 %
Seq. Revenue Growth (TTM) Overall Ranking # 383 # 7 # 1580 # 168 # 3331




Cumulative Revenue growth Comment
Athersys, Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 668.45% year on year, to $ 24 millions if the fiscal year would have ended in Sep 30 2018.
Athersys, Inc's trailing twelve months Revenue growth was higher than company's average 492.57% and higher than 566.39% growth in Jun 30 2018.
But from twelve months ended Jun 30 2018 rise was less at 8.59 % from $22.38 millions recorded in twelve months ending a quarter Jun 30 2018 Ŕlex Ortiz continued.
There is drop-off happening, more obvious observing the If you typical Q/Q TTM historic increase which is higher at 79.14% Ŕlex Ortiz wrote.
The growth is even more impressive from the previous reporting period clinched at 8.59 % jump from $22.38 millions in the period from Jun 30 2018 to Sep 30 2017.

Among companies within the Healthcare sector 7 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 16, from total ranking in previous quarter at 39.

Revenue TTM Q/Q Growth Statistics
High Average Low
657.16 %
79.14 %
-80.64 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 30
Healthcare Sector # 8
Overall # 16

Revenue TTM Y/Y Growth Statistics
High Average Low
1734.17 %
492.57 %
-88.31 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 30
Sector # 86
S&P 500 # 383
Cumulative Revenue growth Comment
Athersys, Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 668.45% year on year, to $ 24 millions if the fiscal year would have ended in Sep 30 2018.
Athersys, Inc's trailing twelve months Revenue growth was higher than company's average 492.57% and higher than 566.39% growth in Jun 30 2018.
But from twelve months ended Jun 30 2018 rise was beneth at 8.59 % from $22.38 millions reported in twelve months ending a quarter before.
It appears to be slowdown developing, more obvious as we look at If you average sequential historic advancement which is better at79.14% Ŕlex Ortiz wrote.
The momentum was even stronger from twelve months ended Jun 30 2018 clinched at 8.59 % jump from $22.38 millions in the period from Jun 30 2018 to Sep 30 2017.

Among companies within the Healthcare sector 7 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 16, from total ranking in previous quarter at 39.

Revenue TTM Q/Q Growth Statistics
High Average Low
657.16 %
79.14 %
-80.64 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 30
Healthcare Sector # 8
Overall # 16

Revenue TTM Y/Y Growth Statistics
High Average Low
1734.17 %
492.57 %
-88.31 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 30
Sector # 86
S&P 500 # 383




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ATHX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ATHX's Competitors
Revenue Growth for Athersys, Inc's Suppliers
Revenue Growth for ATHX's Customers

You may also want to know
ATHX's Annual Growth Rates ATHX's Profitability Ratios ATHX's Asset Turnover Ratio ATHX's Dividend Growth
ATHX's Roe ATHX's Valuation Ratios ATHX's Financial Strength Ratios ATHX's Dividend Payout Ratio
ATHX's Roa ATHX's Inventory Turnover Ratio ATHX's Growth Rates ATHX's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Sep 30 2018 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2018
Abeona Therapeutics Inc.  680.37 %$ 680.365 millions
Wave Life Sciences Ltd.  564.64 %$ 564.645 millions
Collegium Pharmaceutical, Inc  487.25 %$ 487.247 millions
Athersys, Inc  481.70 %$ 481.704 millions
Spark Therapeutics, Inc.  463.65 %$ 463.652 millions
Reva Medical, Inc.  447.06 %$ 447.059 millions
Rigel Pharmaceuticals Inc  440.56 %$ 440.556 millions
Therapeutic Solutions International, Inc.  423.97 %$ 423.968 millions
Kraig Biocraft Laboratories, Inc  417.09 %$ 417.085 millions
Guardion Health Sciences, Inc.  369.28 %$ 369.281 millions
Eyegate Pharmaceuticals Inc  321.04 %$ 321.040 millions
Apollo Medical Holdings, Inc.  313.21 %$ 313.208 millions
Xencor Inc  309.58 %$ 309.577 millions
Regenxbio Inc.  297.16 %$ 297.156 millions
Heat Biologics, Inc.  290.81 %$ 290.807 millions
Bellicum Pharmaceuticals, Inc.  290.48 %$ 290.476 millions
Nantkwest, Inc.  287.50 %$ 287.500 millions
Oncomed Pharmaceuticals Inc  282.26 %$ 282.256 millions
Agenus Inc  281.09 %$ 281.093 millions
Portola Pharmaceuticals Inc  270.35 %$ 270.350 millions
Sanuwave Health, Inc.  268.72 %$ 268.716 millions
Infinity Pharmaceuticals, Inc.  266.67 %$ 266.667 millions
Catasys, Inc.  265.61 %$ 265.607 millions
Rennova Health, Inc.  256.32 %$ 256.320 millions
Aratana Therapeutics, Inc.  249.75 %$ 249.748 millions
Plx Pharma Inc.  247.79 %$ 247.789 millions
Achaogen, Inc.  246.27 %$ 246.274 millions


     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NENE's Profile

Stock Price

NENE's Financials

Business Description

Fundamentals

Charts & Quotes

NENE's News

Suppliers

NENE's Competitors

Customers & Markets

Economic Indicators

NENE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071